Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.32 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.32 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL3404011 | 0.98 | KDM4E (0.33) | KDM4EGAAADORA2AADORA2BPKM | |
| SCHEMBL2612158 | 0.80 | GAA (0.40) | KDM4EGAAADORA2AADORA2BALDH1A1 | |
| SCHEMBL971496 | 0.76 | KDM4E (0.34) | KDM4EGAAADORA2AADORA2BALDH1A1 | |
| SCHEMBL25944182 | 0.76 | ADORA2A (0.32) | KDM4EADORA2AADORA2B | |
| SCHEMBL27880863 | 0.76 | ADORA2A (0.32) | KDM4EADORA2AADORA2B | |
| SCHEMBL14496271 | 0.76 | GAA (0.33) | KDM4EGAAADORA2AADORA2BALDH1A1 | |
| SCHEMBL13438130 | 0.73 | TKT (0.43) | KDM4EGAAADORA2AADORA2BALDH1A1 | |
| SCHEMBL22253434 | 0.71 | KDM4E (0.30) | KDM4E | |
| SCHEMBL2373276 | 0.70 | PKM (0.61) | KDM4EPKMALDH1A1MAPT | |
| SCHEMBL22547319 | 0.67 | LTB4R (0.44) | KDM4EALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110015065-A1 | Substituted Sulfonic Acid Amide Compounds | BASF SE (DE) | 2011-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110015065-A1 | Substituted Sulfonic Acid Amide Compounds | STS, NAPA, NAAA | KDM4E 3294/4885GAA 780/4885ADORA2A 2148/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.